Investors Business DailyWed, 24 Jun 2026 14:29:19 GMTCan Argenx Retake Its Record High — And A Buy Point — On A New Vyvgart Strategy?ARGX-0.11%
Seeking AlphaWed, 24 Jun 2026 05:32:09 GMTargenx SE (ARGX) Discusses R&D Spotlight on Advancing FcRn Leadership in Autoimmune Myositis TranscriptARGX-0.11%
MarketBeatFri, 12 Jun 2026 11:07:03 GMTargenx Eyes More VYVGART Growth as Pipeline Catalysts NearARGX-0.11%
Investors Business DailyWed, 10 Jun 2026 14:15:51 GMTSanofi, An Argenx Rival, Bites The Dust — But A Third Biotech Took The Biggest HitARGX-0.11%
Zacks Investment ResearchWed, 10 Jun 2026 13:11:05 GMTARGX Shares Gain Nearly 9% in a Month: Here's What You Need to KnowARGX-0.11%
Seeking AlphaWed, 10 Jun 2026 05:22:11 GMTargenx SE (ARGX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptARGX-0.11%
Zacks Investment ResearchMon, 08 Jun 2026 16:41:08 GMTSRPT vs. ARGX: Which Stock Is the Better Value Option?ARGX-0.11%
Zacks Investment ResearchMon, 08 Jun 2026 14:01:33 GMTArgenx (ARGX) Soars 5.8%: Is Further Upside Left in the Stock?ARGX-0.11%
MarketBeatFri, 05 Jun 2026 10:03:21 GMTargenx Touts VYVGART Growth, 50,000-Patient Goal at William Blair ConferenceARGX-0.11%
Seeking AlphaFri, 22 May 2026 12:30:31 GMTargenx: The FcRn Franchise Is Becoming An Autoimmune Operating SystemARGX-0.11%
Seeking AlphaTue, 12 May 2026 19:40:42 GMTargenx SE (ARGX) Presents at Bank of America Global Healthcare Conference 2026 TranscriptARGX-0.11%
BenzingaMon, 11 May 2026 17:37:56 GMTArgenx Eyes Larger Patient Pool Following Expanded FDA Nod For Lead Drug For Neuromuscular DiseaseARGX-0.11%
Seeking AlphaThu, 07 May 2026 21:11:21 GMTargenx SE (ARGX) Q1 2026 Earnings Call TranscriptARGX-0.11%
Zacks Investment ResearchMon, 04 May 2026 16:40:30 GMTHRMY or ARGX: Which Is the Better Value Stock Right Now?ARGX-0.11%
